Chile vs Tonga: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
Tonga
100.0%
in 2023
Chile rank
1st
Tonga rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- Tonga
How they compare
Chile currently reports 100.0% against 100.0% in Tonga, a difference of 0.0%.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Chile ahead.
Chile ranks 1st and Tonga ranks 1st of 192 countries.
Across the 2 decades both report, Chile averaged higher in 1 and Tonga in 1.
Head to head by decade
| Decade | Chile | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.6% | 30.0% | 23.6% | Chile |
| 2020s | 94.0% | 100.0% | 6.0% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or Tonga?
- Chile, at 100.0% against 100.0% in Tonga as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and Tonga?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Tonga?
- 14 years are reported by both, from 2010 to 2023.
- How do Chile and Tonga rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and Tonga ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.